Generation Bio Co.
GBIO
$0.3908
$0.01654.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 45.52% | 252.00% | 364.89% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.52% | 252.00% | 364.89% | -- | -- |
| Cost of Revenue | -43.44% | -35.65% | -29.46% | -42.04% | 20.41% |
| Gross Profit | 57.13% | 73.57% | 49.38% | 63.82% | -4.34% |
| SG&A Expenses | -37.51% | -17.67% | -21.85% | -13.97% | 17.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.60% | -27.56% | -25.85% | -28.98% | 19.06% |
| Operating Income | 47.05% | 46.69% | 35.99% | 40.62% | -10.76% |
| Income Before Tax | 39.23% | 45.83% | 34.23% | -132.26% | -8.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 39.23% | 45.83% | 34.23% | -132.26% | -8.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.23% | 45.83% | 34.23% | -132.26% | -8.58% |
| EBIT | 47.05% | 46.69% | 35.99% | 40.62% | -10.76% |
| EBITDA | 48.33% | 48.33% | 37.28% | 42.18% | -11.26% |
| EPS Basic | 39.90% | 46.51% | 35.10% | -110.55% | 2.36% |
| Normalized Basic EPS | 48.96% | 50.56% | 40.18% | 50.24% | 2.35% |
| EPS Diluted | 39.90% | 46.51% | 35.10% | -110.55% | 2.36% |
| Normalized Diluted EPS | 48.96% | 50.56% | 40.18% | 50.24% | 2.35% |
| Average Basic Shares Outstanding | 1.10% | 1.26% | 1.33% | 10.30% | 11.20% |
| Average Diluted Shares Outstanding | 1.10% | 1.26% | 1.33% | 10.30% | 11.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |